Zantac / Ranitidine (NDMA Cancer) Attorney in Memphis, Tennessee

Zantac Litigation in Memphis — URGENT: 1-Year SOL

Tennessee's 1-year statute of limitations applies to Memphis-area Zantac claimants — making immediate legal action absolutely critical. Memphis's logistics-sector workforce (FedEx, shipping, warehousing) represents demographics with high rates of occupational GI stress and corresponding OTC ranitidine use. Tennessee applies Daubert under Tenn. R. Evid. 702. National plaintiffs' counsel strongly recommend Delaware Superior Court as primary filing venue for Tennessee claimants. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Immediate Resources for Memphis Zantac Claimants

Memphis Zantac claimants must immediately gather pharmacy records from Walgreens, CVS, Kroger, and employer pharmacy benefit programs including FedEx's pharmacy plan. Methodist Le Bonheur and West Cancer Center records documenting cancer diagnosis, staging, and treatment are critical. Tennessee's 1-year SOL means any delay risks claim forfeiture — contact qualified Zantac plaintiffs' counsel today.